The primary purpose of the Mouse Models Core Facility is the proficient affordable generation of geneticallymodified mice for both basic and translational cancer research by Moffitt investigators. Advances inexperimental manipulation of the laboratory mouse via gene expression, mutation, or deletion strategieshave propelled major progress in the fields of developmental biology, physiology, and pathology. Transgenicand targeted mice serve as incomparable models of gene function (or dysfunction) in context in vivo andthereby contribute greatly to our understanding of dynamic, complex oncogenic mechanisms. These modelsare also invaluable in studies of the prevention, treatment, and etiology of cancer and other diseases. Forinvestigators, the disadvantages or deterrents to studying these mouse models are the substantial cost, time,equipment, and expertise required for their derivation and examination. The Mouse Models Core also offersluciferase expressing tumor cell lines and bioluminescent imaging with the Xenogen MS workstation forimproved study of traditional xenograft mouse models.The specific objectives of the core are to:- Advise investigators on the overall strategy and design of transgenic and targeting vectors;- Provide relevant plasmid vectors and lambda genomic libraries;- Provide embryonic stem (ES) cells and instruction in their culture, transfection, selection, screening;- Provide pronuclear DMA microinjection services to generate transgenic founder mice;- Provide blastocyst microinjection services to generate germline chimeras from targeted ES cells;- Advise and assist investigators in the genotypic and phenotypic analyses of mice;- Provide cryopreservation and pathogen-free rederivation of genetically engineered mouse models; and- Provide luciferase-tagged tumor cell lines and bioluminescent imaging for xenograft mouse models.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA076292-09
Application #
7516328
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-02-01
Project End
2012-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
9
Fiscal Year
2007
Total Cost
$45,996
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
de Mingo Pulido, Álvaro; Gardner, Alycia; Hiebler, Shandi et al. (2018) TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer. Cancer Cell 33:60-74.e6
Divakaran, Anand; Talluri, Siva K; Ayoub, Alex M et al. (2018) Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor. J Med Chem 61:9316-9334
McIntyre, Jessica; Jiménez, Julio; Rivera, Yonaira M et al. (2018) Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. J Cancer Educ 33:833-841
Li, Gongbo; Boucher, Justin C; Kotani, Hiroshi et al. (2018) 4-1BB enhancement of CAR T function requires NF-?B and TRAFs. JCI Insight 3:
Rivera, Y M; Moreno, L; Briant, K J et al. (2018) Developing Sustainable Cancer Education Programs: Training Public Health Students to Deliver Cancer 101 in Puerto Rico. J Cancer Educ 33:128-133
Saltos, Andreas; Khalil, Farah; Smith, Michelle et al. (2018) Clinical associations of mucin 1 in human lung cancer and precancerous lesions. Oncotarget 9:35666-35675
Gjyshi, Anxhela; Dash, Sweta; Cen, Ling et al. (2018) Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine. Sci Rep 8:8291
Maharaj, Kamira; Powers, John J; Achille, Alex et al. (2018) Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia. Blood Adv 2:3012-3024
Schaal, Courtney M; Bora-Singhal, Namrata; Kumar, Durairaj Mohan et al. (2018) Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Mol Cancer 17:149
Zhu, Genyuan; Brayer, Jason; Padron, Eric et al. (2018) OMIP-049: Analysis of Human Myelopoiesis and Myeloid Neoplasms. Cytometry A 93:982-986

Showing the most recent 10 out of 1254 publications